Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
EMR
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q2.23
-7%
1.29
vs 1.38
Q3.23
-16%
1.29
vs 1.53
Q4.23
+56%
1.22
vs 0.78
Q1.24
+30%
1.36
vs 1.05
Q2.24
+11%
1.43
vs 1.29
Q3.24
+15%
1.48
vs 1.29
Q4.24
+13%
1.38
vs 1.22
Q1.25
+9%
1.48
vs 1.36
Q2.25
+5%
1.5
vs 1.43
Q3.25
+9%
1.62
vs 1.48
Sales Growth
YoY
Current
Estimates
Q2.23
-21%
3.9B vs 5B
Q3.23
-24%
4.1B vs 5.4B
Q4.23
+22%
4.1B vs 3.4B
Q1.24
+17%
4.4B vs 3.8B
Q2.24
+11%
4.4B vs 3.9B
Q3.24
+13%
4.6B vs 4.1B
Q4.24
+1%
4.2B vs 4.1B
Q1.25
+1%
4.4B vs 4.4B
Q2.25
+5%
4.6B vs 4.4B
Q3.25
+7%
4.9B vs 4.6B
Return on Equity
QoQ
Q2.23
+46%
0.46
vs 0.07
Q3.23
+4%
0.04
vs 0.46
Q4.23
+1%
0.01
vs 0.04
Q1.24
+2%
0.02
vs 0.01
Q2.24
+2%
0.02
vs 0.02
Q3.24
+5%
0.05
vs 0.02
Q4.24
+3%
0.03
vs 0.05
Q1.25
+3%
0.03
vs 0.03
Institutionnal Ownership
QoQ
Q2.23
1832
1.8K
vs 1.8K
2%
Q3.23
1850
1.9K
vs 1.8K
1%
Q4.23
1922
1.9K
vs 1.9K
4%
Q1.24
2019
2K
vs 1.9K
5%
Q2.24
2000
2K
vs 2K
-1%
Q3.24
1997
2K
vs 2K
0%
Q4.24
2156
2.2K
vs 2K
8%
Q1.25
2093
2.1K
vs 2.2K
-3%
seekingalpha.com
2 hours ago
seekingalpha.com
3 hours ago
zacks.com
10 hours ago
zacks.com
12 hours ago
zacks.com
18 hours ago
seekingalpha.com
20 hours ago
Quote Panel
Key Metrics
Forecast
2026-Revenue
2026-EPS
2026-EBITDA
Analyst rating
Price Target
135.00(4.91%)
Number of analyst
1
Last analyst upgrade/downgrade
Barclays
downgradePrevious: Equal-Weight
2025-03-10
Now: Underweight
Stephens
downgradePrevious: Not converted
2024-10-16
Now: Equal-Weight
Morgan Stanley
initialisePrevious: Overweight
2024-09-06
Now: Underweight
Deutsche Bank
upgradePrevious: Buy
2024-05-08
Now: Positive
Relative Strength
EMR
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
---|---|---|---|